.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Preimplantation genetic testing for monogenic disorders allows embryos to be selected before transfer when a couple carries a known pathogenic variant and the familial mutation is well characterized. The approach has been used for conditions ranging from thalassemia and cystic fibrosis to inherited cancer syndromes. For reproductive specialists, the pathway requires genetic counseling, validated molecular testing, IVF, embryo biopsy and coordinated laboratory quality assurance. PGT-M is not a substitute for prenatal diagnosis; confirmatory prenatal testing is still commonly discussed because embryo testing has technical limitations and residual risk. The technology is particularly valuable in families with a high reproductive burden from severe inherited disease, but access and cost may limit availability.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Preimplantation genetic testing for monogenic disorders allows embryos to be selected before transfer when a couple carries a known pathogenic variant and the familial mutation is well characterized. The approach has been used for conditions ranging from thalassemia and cystic fibrosis to inherited cancer syndromes. For reproductive specialists, the pathway requires genetic counseling, validated molecular testing, IVF, embryo biopsy and coordinated laboratory quality assurance. PGT-M is not a substitute for prenatal diagnosis; confirmatory prenatal testing is still commonly discussed because embryo testing has technical limitations and residual risk. The technology is particularly valuable in families with a high reproductive burden from severe inherited disease, but access and cost may limit availability.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
